INTERPRETATION This investigation revealed that medial gastrocnemius muscle volume can be reliably estimated in a clinically feasible manner in typically developing children and those with SCP.
Children with spastic cerebral palsy (SCP) have delayed muscle growth compared with typically developing peers. 1 The deficits in muscle volume occur as early as 15 months of age, 2 continuing into adolescence. 3, 4 This is caused by reduced growth rates during childhood. 5 As the morphology of a muscle is related to its force-generating capabilities, 6 estimating its volume has many useful clinical applications, such as evaluating the efficacy of treatment interventions. 7, 8 Furthermore, insight into muscle-specific deficits may also have ramifications for selecting and optimizing treatment interventions, such as injections of botulinum neurotoxin A (BoNT-A), where the dosage could be delivered relative to the size of the muscle as opposed to mass. 9 A method for estimating muscle volume in a clinically feasible manner, taking into consideration cost, acquisition/processing time, and clinician training, would be of great value for managing those diagnosed with SCP.
Although magnetic resonance imaging (MRI) is commonly considered the criterion standard for estimating muscle volume, it can be inaccessible, expensive, time-consuming, and often intimidating to young children. Threedimensional freehand ultrasonography (3DfUS) is an alternative technique for estimating muscle volume. 10 It combines a two-dimensional B-mode ultrasound (2DUS) and motion-tracking system to create three-dimensional reconstructions of anatomical regions, where estimating muscle volume has been shown to be valid and reliable in various lower limb muscles. [11] [12] [13] Compared with MRI, 3DfUS is more affordable and feasible for use in young children owing to its short acquisition time. However, it can require a lengthy post-processing time, substantial clinician training, and access to a motion-tracking system. Conventional 2DUS is a more convenient option as it is accessible in most rehabilitation settings. As muscle volume cannot be estimated using 2DUS, surrogate outcome parameters such as anatomical cross-sectional area (aCSA) are used. 14 Significant differences in the mean aCSA of six thigh muscles were shown between children with SCP and typically developing peers, 6 but comprehensive reliability analyses are yet to be established. Reliability is important because of methodological variations, such as where along a muscle the ultrasound image is extracted, or the effect of muscle deformation caused by pressure from the linear ultrasound transducer. There is also little information about the muscle border segmentation, which may be challenging in hyperechoic SCP muscles. 15 Finally, as multiple clinicians perform measurements in the clinical environment, the interrater reliability should also be established.
Despite the methodological feasibility of extracting aCSA, and the aforementioned differences in aCSA between children with SCP and typically developing peers, correlations with muscle strength were shown to be higher with muscle volume than aCSA in a cohort of typically developing children. 16 As such, estimations of medial gastrocnemius muscle volume have been performed by multiplying the aCSA with tibia length in a cohort of nine children (18 legs) with SCP, aged 2 to 6 years.
14 However, the resulting large standard error of estimate (SEE) found in the proposed regression equation limits its individual clinical application. As 2DUS is a clinically feasible technique, it is worthwhile verifying whether the SEE can be further reduced. This could be achieved by developing a regression equation based on a more homogenous cohort of children with SCP, such as similar Gross Motor Function Classification system (GMFCS) levels. Another method that might decrease the SEE is extracting the ultrasound image with respect to muscle length, instead of tibia length or muscle-tendon unit (MTU) length. This is because children with SCP often present with shorter muscles than typically developing children. 17, 18 Furthermore, when estimating muscle volume with the resulting aCSA, multiplying by muscle length may provide better estimations than with tibia or MTU lengths.
In the current investigation, the aCSA of the medial gastrocnemius at three standardized locations along the muscle was estimated and compared in three age-matched cohorts: a comparison group of typically developing children and two groups of children with SCP in GMFCS levels I and II. Interacquisition and interprocessor repeated measures were investigated. Using the aCSA location that was most reliable, correlations were calculated with muscle volume, where it was investigated whether multiplying aCSA by MTU or muscle length improved its relation to muscle volume. The regression equation containing the lowest SEE was cross-validated using a leave-one-out approach. The first hypothesis states that the estimations of aCSA significantly differ between the typically developing and SCP cohorts. The second hypothesis states that the estimations of muscle volume based on aCSA improve when multiplied by either MTU or muscle length, with the greatest effects in the SCP cohorts. The third hypothesis states that the difference between measured and estimated muscle volume in new cohorts of typically developing and SCP children is smaller than previously reported changes to the medial gastrocnemius volume after interventions, implying the clinical utility of a 2DUS approach.
METHOD Participants
Data collection was performed as part of an ongoing research project (muscle morphology and function in SCP) from January to December 2016, where children diagnosed with SCP and typically developing peers were recruited through the clinical motion analysis laboratory at the University Hospital of Leuven. To minimize bias and ensure appropriate matching of the groups, the following criteria was applied to the acquired data: (1) between 5 and 15 years of age, (2) GMFCS levels I and II, (3) no previous orthopaedic or neurological surgery, and (4) no BoNT-A injections 6 months before the measurement. To develop the regression equation for estimating muscle volume, 15 age-and weight-matched children were identified and selected for each group (typically developing, SCP GMFCS I and SCP GMFCS II). Interacquisition and interprocessor repeated measures were acquired for 30 of these children (10 in each group), and used for the reliability analysis for estimating aCSA. The primary outcome parameters were not extracted until after the final groups had been determined, further avoiding possible bias. The Ethical Committee of the University Hospitals of Leuven approved the experimental protocol (s57234). Written informed consent for participation was acquired from all parents of the children under the age of 12 years, and from the children 12 years and over.
Instrumentation
For this investigation, 3DfUS was used. 10 It consists of a Telemed-Echoblaster 128 Ext-1Z ultrasound system with a 5.9 cm 10 MHz linear ultrasound transducer (HL9.0/60/ 128Z), and an OptiTrack V120:Trio motion-tracking system (NaturalPoint, Corvallis, OR, USA) with three fixed optical cameras and a spatial resolution of 1 mm. The ultrasound acquisition settings were kept constant throughout the investigation (frequency, 10 MHz; depth, 5 cm; focus, 1.8-2.8 cm; gain, 46%; dynamic range, 44 dB and unaltered time-gain compensation), with the images recorded at 30 Hz, and the motion-tracking system images recorded at 120 Hz. To simultaneously acquire data, a signal trigger was used.
What this paper adds
• Medial gastrocnemius anatomical cross-sectional area (aCSA) can be reliably estimated in children with spastic cerebral palsy.
• The location of the anatomical cross-section should be taken with respect to muscle and not bone length.
• Medial gastrocnemius volume can be reliably estimated by multiplying aCSA and muscle length.
• The errors in volume estimations are smaller than reported differences after interventions.
Acquisition
The most affected leg of the children with SCP according to their most recent clinical examination was measured, while a coin was flipped to determine the measured leg in the typically developing group. Mass was recorded for all participants. Before measurement, each participant lay in a prone position with the shank flexed to an angle of 25°, reducing the bi-articular stretch of the gastrocnemius and allowing the ankle to assume a natural resting angle. A cushioned belt was also strapped over the thigh. The sagittal plane knee and ankle angles were measured with a goniometer. The same researcher performed all the 3DfUS acquisitions, conducting two consecutive acquisitions within the same measurement session (Fig. 1a) . Copious amounts of gel were used, and the transducer was held perpendicular to the surface of the skin throughout the acquisition. Images were acquired in a transverse orientation from the posterior aspect of the knee, over the medial gastrocnemius until the end of the calcaneus. In cases of suspected muscle contraction or movement of the leg, the acquisition was repeated.
Processing
The three-dimensional reconstructions were performed in a custom-made software package, 10 while muscle volume was calculated by manually drawing equally spaced transverse plane segmentations along the medial gastrocnemius border, using MeVisLab (http://www.mevislab.de). The proximal origin of the muscle was standardized as the inferior margin of the medial condyle of the tibia, whereas the insertion was standardized as the most distal visible image of the medial gastrocnemius. 19 The segmentations summed 10% of all the available ultrasound images of the muscle, with gaps being linearly interpolated. 10 For between-group comparisons, muscle volume was normalized to mass. To provide MTU and muscle length, the aforementioned anatomical points were used, along with the first visible image of the calcaneus in the transverse plane (Fig. 1b) . The coordinates of each location were extracted from the three-dimensional reconstruction and the lengths were calculated using a custom-made Python package. To allow between-group comparisons, muscle length was normalized to MTU length. To estimate aCSA, transverse ultrasound images were extracted from the three-dimensional reconstructions at 40%, 50%, and 60% of the muscle length (Fig. 1b) . These locations were chosen as the aCSA around these regions of the muscle visually appeared largest, and was in line with previous investigations. 14, 16 Using FIJI (http://www.fiji.sc), muscle borders were segmented to provide the aCSA. 20 Processor one segmented the ultrasound images from the first set of acquisitions, while processor two segmented the second set of acquisitions, providing the interacquisition and interprocessor analyses (Fig. 1a) . A representative segmentation of an aCSA can be found in Figure 1b . 2DUS image 40% ML 2DUS image 50% ML 2DUS image 60% ML aCSA-40% ML aCSA-50% ML aCSA-60% ML aCSA-40% ML aCSA-50% ML aCSA-60% ML 2DUS image 40% ML 2DUS image 50% ML 2DUS image 60% ML 
Statistical analysis
All analyses were performed using SPSS (Version 22; SPSS, Inc., Chicago, IL, USA). Normal distribution was determined by plotting the data and visually inspecting the histogram. A Levene's test determined homogeneity of variance for age, mass, acquisition joint angles, MTU length, aCSA, muscle volume, and muscle length between the three cohorts, where a one-way analysis of variance (ANOVA) with a post-hoc Scheffe test determined statistically significant differences (p<0.050). 21 Relative reliability was evaluated by the intraclass correlation coefficient (model 3.1) and 95% confidence intervals (CIs). 22 Absolute reliability was evaluated by the standard error of measurement (SEM), calculated from the square root of the mean square error from a one-way ANOVA. Paired Student's t-tests determined differences in aCSA between both processors. A Bland-Altman plot was independently inspected by two processors to evaluate evidence of systematic bias. 23 The aCSA location with the lowest SEM as a percentage of the mean of both processors was chosen for the remaining analyses. With muscle volume as the dependent variable, and aCSA multiplied by MTU and muscle length as the independent variable, regressions and the SEE were calculated. An analysis of covariance (ANCOVA) investigated differences between the regression equation intercepts and slopes of the three cohorts. The intercepts were tested by adding two categorical variables to define the GMFCS group level, used in the ANCOVA to determine a significant difference between the constants of the three equations. Interaction variables describing the relationship between the independent variable (aCSA9muscle length) and the categorical variable (GMFCS level) were created and applied in the ANCOVA to define any significant differences between the gradients of the equations. To validate the regression equation, a leave-one-out cross validation was executed by defining the regression on 44 children, validating it on the remaining one, and repeating it for each child. An independent samples Student's t-test evaluated differences between the estimated and measured muscle volume.
RESULTS

Group characteristics
Descriptive statistics for all cohorts in the development group can be found in Table I . On visual inspection of the histogram for each parameter, all data appeared to be normally distributed. The post-hoc Scheffe method revealed no significant differences between age, mass, acquisition joint angles, or MTU lengths between cohorts. Statistically significant deficits in the main outcome parameters were found in the groups with SCP compared with the typically developing group. The same was found in the group with SCP in GMFCS level II compared with the group with SCP in GMFCS level I, except for absolute muscle length.
Reliability analysis
The descriptive statistics for the subgroups and the results of the reliability analysis can be found in Table II . The lowest intraclass correlation coefficient and widest CIs were 0.98 and 0.96 to 0.99 respectively. The highest absolute SEM was 0.32 cm² (aCSA 50%) and 6.73% as a percentage of the mean (aCSA 40%). The lowest SEM as a percentage of the mean was 6.49% (aCSA 50%), so this was chosen for estimating muscle volume. There were no significant differences in the aCSA between processors one and two, so the mean of both was used. The Bland-Altman plot revealed no evidence of systematic bias (Fig. S1 , online supporting information).
Development of regression equation
An overview of all correlations can be found in Table III , while graphical representations are presented in Figure S2 (online supporting information). aCSA significantly correlated with muscle volume, and when multiplied with either MTU or muscle length all correlations increased further. The ANCOVA revealed no significant difference between the intercept and slope of the regression equations in the three cohorts; therefore, the data from all cohorts were pooled. aCSA multiplied by MTU length resulted in an r 2 of 0.85 and an SEE of 14.08% (p≤0.001), while aCSA multiplied by muscle length resulted in an r² of 0.89 and an SEE of 11.69% (p≤0.001). The latter was chosen for validation because of the slightly lower SEE, while both the constant and the slope were also statistically significant (p=0.008 and p≤0.001 respectively). Although an intercept of zero is to be expected, the range of data upon which the regression equation was calculated (18-75 ml of muscle volume) would be an extrapolation, and imply a stronger relation. The final regression equation was estimated as muscle volume=5.472+0.526 (aCSA9muscle length), with aCSA in square centimetres and muscle length in centimetres.
Validation of regression equation
The leave-one-out cross validation method led to a nonsignificant mean absolute difference between measured and estimated muscle volume of 3.77 ml (SD 2.9) (p=0.99), with a significant correlation between the two (r=0.95, p≤0.001). A graphical representation can be found in Figure S3 (online supporting information) .
DISCUSSION
The first aim of this investigation was to ascertain the error in estimating aCSA from three different locations along the medial gastrocnemius. The research design incorporated interacquisition and interprocessor reliability from within the same-session. Results revealed high intraclass correlation coefficient values with narrow CIs, and SEMs ranging from 0.30 to 0.32 cm 2 (6.49-6.73% of the mean). The need to apply pressure to visualize the convexshaped medial gastrocnemius with a linear ultrasound probe may have been a source of extrinsic error during acquisition. During the processing, errors may have been introduced when segmenting the muscle border, as it was not always visible, especially in the SCP images, where the medial gastrocnemius has been reported to be hyperechoic. 15 This investigation also identified that the aCSA at 50% of muscle length was consistently larger than those at 40% and 60% (Table I) . This is an important finding, implying that moving a short distance proximal or distal to the aCSA at 50% might be an additional source of extrinsic error when performing repeated measurements using 2DUS. Owing to the significant differences in aCSA between the cohorts, the first hypothesis was confirmed. As the aCSA at 50% of muscle length had the lowest SEM as a percentage of the mean, and has also been used in previous investigations, 9 it was chosen as the aCSA location for the subsequent analyses.
The second aim of this investigation was to develop a regression equation for estimating muscle volume based on aCSA, and whether this could be improved with the addition of MTU or muscle length. The choice of MTU length as a surrogate parameter for lower leg length appeared to be vindicated, as it was not significantly different between groups. This also supported a 25°knee and resting ankle angle for standardized measurements in children with SCP and typically developing peers. A novel aspect of this investigation was the inclusion of muscle length, as previous differences between typically developing and SCP cohorts have been reported. 17, 18 This was reaffirmed here (Table I) , as the SCP GMFCS I and II cohorts had significantly shorter muscles than the typically developing cohort. The inclusion of MTU and muscle Per cent SEM relative to the mean value was calculated as the mean of both processors one and two. TD, typically developing; SCP, spastic cerebral palsy; GMFCS, Gross Motor Function Classification System; aCSA, anatomical cross-sectional area; ICC, intraclass correlation coefficient; CI, confidence interval; SEM, standard error of measurement. length improved estimations of muscle volume to similar extents, with the biggest effects occurring in the SCP GMFCS II cohort, confirming the second hypothesis. As there were no significant differences between the intercepts or gradients of the regression equations between the cohorts, new equations were created based on pooled data. The regression equation using aCSA multiplied by muscle length produced the best results, so this was chosen for validation. This investigation also found a similar explained variance but lower SEE (r²=0.89; SEE=11.69%) with respect to a previously reported regression equation based on aCSA multiplied by tibia length (r²=0.90; SEE=15.5%). 14 This highlights the advantage of extracting aCSA with respect to muscle length, especially for a heterogeneous SCP cohort. The aforementioned regression equation was also not validated, 14 which is another novelty of the current investigation in determining the efficacy of the regression equation.
The third aim of this investigation was to determine whether muscle volume estimations based on aCSA multiplied by muscle length were sufficient to detect previously reported changes to the medial gastrocnemius volume after interventions. There were no significant differences between estimated and measured muscle volumes, with an absolute mean difference of 3.77 ml (9.7% of the mean). After a home-based plantar-flexor strength training programme in children with SCP, the medial gastrocnemius volume increased by a mean of 11.1 ml after 5 weeks, 8 while in a different SCP cohort a surgical intervention to correct a plantar flexion contracture led to a long-term increase in muscle volume by a mean of 4.8 ml. 7 Based on these two findings, together with the results of this investigation, muscle volume estimations using aCSA multiplied by muscle length are sufficiently sensitive for evaluating changes after these interventions.
Limitations
There are several methodological considerations that should be addressed. First, the outcome parameters were acquired using 3DfUS, which led to aCSA, MTU, and muscle length being extracted in a post-processing manner that is not possible with 2DUS. Consequently, this investigation cannot confirm the level of reliability when using 2DUS, but findings from two earlier investigations with 2DUS to estimate aCSA and muscle length are encouraging. 2, 24 Second, the proximal origin of the medial gastrocnemius was defined by the medial condyle of the tibia instead of the real anatomical origin at the medial femoral condyle. Visually identifying the medial gastrocnemius at the medial tibial condyle was easier than at the medial femoral condyle, 19 but this will have introduced a systematic underestimation of MTU and muscle length. Nonetheless, the results of this investigation revealed that the SCP cohorts still presented with shorter muscles, but no difference in MTU length compared with the typically developing cohort, justifying the method. However, the proposed regression equation is only applicable if the same definition of the origin of the muscle is used. Third, this investigation did not include a between-session reliability analysis for extracting aCSA, which should be undertaken in future investigations.
CONCLUSION
This investigation addressed three specific topics. First, it was demonstrated that the aCSA extracted at 40%, 50%, and 60% of the medial gastrocnemius length can be reliably estimated using an interacquisition and interprocessor design in cohorts of typically developing children and those with SCP in GMFCS levels I and II. This is encouraging for measurements in the clinical environment that are acquired or processed by different people. However, care is needed when defining where the ultrasound image is taken along the muscle. Second, a regression equation was developed for estimating medial gastrocnemius volume based on aCSA multiplied by muscle length. The equation based on pooled data from all the cohorts was revealed to be stronger and with less error than a previously reported regression equation using aCSA and tibia length. Third, the regression equation was validated, revealing an absolute mean difference of 3.77 ml when estimating muscle volume. This discrepancy is lower than previously reported mean increases in medial gastrocnemius volume after two types of intervention. Future investigations should evaluate the between-session reliability of estimating aCSA, other clinically relevant muscles, as well as larger age ranges and GMFCS levels. Figure S2 : Relationship between the measured muscle volume with the three independent variables: (1) anatomical cross-sectional area (aCSA), (2) muscle-tendon unit (MTU)9aCSA, and (3) muscle length (ML)9aCSA. TD, typically developing; GMFCS, Gross Motor Function Classification System; MV, muscle volume. Figure S3 : Relationship between the measured and estimated muscle volumes, with the estimation based on anatomical crosssectional area multiplied by muscle length (aCSA9ML). TD, typically developing; GMFCS, Gross Motor Function Classification System; MV, muscle volume.
